Property, Plant and Equipment, Gross of GYRE THERAPEUTICS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
GYRE THERAPEUTICS, INC. quarterly Property, Plant and Equipment, Gross in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • GYRE THERAPEUTICS, INC. Property, Plant and Equipment, Gross for the quarter ending 31 Dec 2025 was $31,175,000, a 5.8% increase year-over-year.
Source SEC data
View on sec.gov
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Change (%)

GYRE THERAPEUTICS, INC. Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $31,175,000 +$1,696,000 +5.8% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 $30,542,000 +$777,000 +2.6% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $29,826,000 +$1,350,000 +4.7% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $29,595,000 +$1,359,000 +4.8% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $29,479,000 +$1,926,000 +7% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 $29,765,000 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $28,476,000 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $28,236,000 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $27,553,000 +$5,846,000 +27% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 $21,707,000 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q4 2018 $671,000 -$1,628,000 -71% 31 Dec 2018 10-K 08 Mar 2019 2018 FY
Q4 2017 $2,299,000 -$5,000 -0.22% 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q4 2016 $2,304,000 -$4,095,000 -64% 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q4 2015 $6,399,000 -$1,161,000 -15% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q4 2014 $7,560,000 -$1,073,142 -12% 31 Dec 2014 10-K 09 Mar 2016 2015 FY
Q4 2013 $8,633,142 +$3,125,142 +57% 31 Dec 2013 8-K/A 23 Oct 2015
Q4 2012 $5,508,000 -$12,359,000 -69% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $17,867,000 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.